fluorodeoxyglucose f18 has been researched along with 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Q; Chen, X; Li, Z; Niu, G | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
| Article | Year |
|---|---|
Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzoquinones; Cell Line, Tumor; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; Mice, Nude; Neoplasm Transplantation; Organometallic Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Receptor, ErbB-2; Tissue Distribution; Trastuzumab | 2009 |